Current concepts of the intestinal microbiota and prospects for microbiocenosis adjustment: A review

Cover Page

Cite item

Full Text

Abstract

The review presents current data on the interaction between the human body and the community of microorganisms inhabiting its gastrointestinal tract. The terminology and methods for analyzing quantitative and qualitative characteristics of gut microbiota are presented. The review also focuses on the concepts of eubiosis, dysbiosis, and the possibilities of correcting dysbiosis with probiotics and probiotic foods.

Full Text

Restricted Access

About the authors

Anatoly I. Khavkin

Pirogov Russian National Research Medical University; Research Clinical Institute of Childhood; Belgorod State University

Author for correspondence.
Email: gastropedclin@gmail.ru
ORCID iD: 0000-0001-7308-7280

D. Sci. (Med.), Prof., Pirogov Russian National Research Medical University, Research Clinical Institute of Childhood, Belgorod State University

Russian Federation, Moscow; Moscow; Belgorod

Andrey I. Vashura

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology

Email: avashura@gmail.com
ORCID iD: 0000-0002-4296-3345

Cand. Sci. (Med.), Dmitry Rogachev National Medical Research Center of Pediatric Hematology

Russian Federation, Moscow

Tatiana A. Kovtun

Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology; JSC PROGRESS

Email: tatianakovtundoc@gmail.com
ORCID iD: 0000-0002-0303-6899

Cand. Sci. (Med.), Dmitry Rogachev National Medical Research Center of Pediatric Hematology, JSC PROGRESS.

Russian Federation, Moscow; Moscow

Elena V. Tabulovich

JSC PROGRESS

Email: etabulovich@progressfood.ru

Department Head, JSC PROGRESS

Russian Federation, Moscow

References

  1. Schlaeppi K, Bulgarelli D. The plant microbiome at work. Mol Plant Microbe Interact. 2015;28(3):212-7. doi: 10.1094/MPMI-10-14-0334-FI
  2. Islam MR, Arthur S, Haynes J, et al. The Role of Gut Microbiota and Metabolites in Obesity-Associated Chronic Gastrointestinal Disorders. Nutrients 2022;14(3):624. doi: 10.3390/nu14030624
  3. Markowiak-Kopeć P, Śliżewska K. The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome. Nutrients. 2020;12(4):1107. doi: 10.3390/nu12041107
  4. Joseph N, Vasodavan K, Saipudin NA, et al. Gut microbiota and short-chain fatty acids (SCFAs) profiles of normal and overweight school children in Selangor after probiotics administration. J Funct Foods. 2019;57:103-11.
  5. Czajkowska A, Szponar B. Krótkołańcuchowe kwasy tłuszczowe (SCFA) jako produkty metabolizmu bakterii jelitowych oraz ich znaczenie dla organizmu gospodarza. Postepy Hig Med Dosw (online). 2018;72:131-42. doi: 10.5604/01.3001.0011.6468
  6. Rakhra V, Galappaththy SL, Bulchandani S, Cabandugama PK. Obesity and the Western Diet: How We Got Here. Mo Med. 2020;117(6):536-8.
  7. Mueller NT, Zhang M, Juraschek SP, et al. Effects of high-fiber diets enriched with carbohydrate, protein, or unsaturated fat on circulating short chain fatty acids: Results from the OmniHeart randomized trial. Am J Clin Nutr. 2020;111(3):545-54. doi: 10.1093/ajcn/nqz322
  8. Almeida A, Mitchell AL, Boland M, et al. A new genomic blueprint of the human gut microbiota. Nature. 2019;568(7753):499-504. doi: 10.1038/s41586-019-0965-1
  9. Iacob S, Iacob DG, Luminos LM. Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats. Front Microbiol. 2019;9:3328. doi: 10.3389/fmicb.2018.03328
  10. Yoo JY, Groer M, Dutra SVO, et al. Gut Microbiota and Immune System Interactions. Microorganisms. 2020;8(10):1587. doi: 10.3390/microorganisms8101587
  11. Blaak EE, Canfora EE, Theis S, et al. Short chain fatty acids in human gut and metabolic health. Benef Microbes. 2020;11:411-55. doi: 10.3920/BM2020.0057
  12. Lei J, Sun L, Huang S, et al. The antimicrobial peptides and their potential clinical applications. Am J Transl Res. 2019;11(7):3919-31.
  13. Giuffrè M, Moretti R, Campisciano G, et al. You Talking to Me? Says the Enteric Nervous System (ENS) to the Microbe. How Intestinal Microbes Interact with the ENS. J Clin Med. 2020;9(11):3705. doi: 10.3390/jcm9113705
  14. Lloyd-Price J, Abu-Ali G, Huttenhower C. The healthy human microbiome. Genome Med. 2016;8(1):51. doi: 10.1186/s13073-016-0307-y
  15. Комарова ОН, Хавкин АИ. Кисломолочные продукты в питании детей: пищевая и биологическая ценность. Российский вестник перинатологии и педиатрии. 2017;62(5):80-6 [Komarova ON, Havkin AI. Cultured milk foods in children’s nutrition: nutritional and biological value. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2017;62(5):80-6 (in Russian)]. doi: 10.21508/1027-4065-2017-62-5-80-86
  16. Хавкин А.И., Федотова О.Б., Волынец Г.В., и др. Результаты проспективного сравнительного открытого рандомизированного исследования по изучению эффективности йогурта, обогащенного пребиотиками и пробиотиками, у детей раннего возраста, перенесших острую респираторную инфекцию. Вопросы детской диетологии. 2019;17(1):29-37 [Khavkin АI, Fedotova OB, Volynets GV, et al. The results of a prospective comparative open-label randomised study of the effectiveness of a probiotic- and prebiotic-fortified yogurt in small children after an acute respiratory infection. Vopr. det. dietol. (Pediatric Nutrition). 2019;17(1):29-37 (in Russian)]. doi: 10.20953/1727-5784-2019-1-29-37
  17. Богданова Н.М., Хавкин А.И., Колобова О.Л. Перспективы использования ферментированных молочных продуктов у детей с первичной гиполактазией взрослого типа. Рос вестн перинатол и педиатр. 2020;65(3):160-8 [Bogdanova NM, Khavkin AI, Kolobova OL. Prospects of fermented milk products in children with primary hypolactasia of the adult type. Ros Vestn Perinatol i Pediatr. 2020;65(3):160-8 (in Russian)]. doi: 10.21508/1027-4065-2020-65-3-160-168
  18. Хавкин А.И., Волынец Г.В., Федотова О.Б., и др. Применение кисломолочных продуктов в питании детей: опыт и перспективы. Трудный пациент. 2019;17(1-2):28-36 [Khavkin AI, Volynets GV, Fedotova OB, et al. The use of dairy productsin children’s diet: experience and prospects. Trudnyi patsient. 2019;17(1-2):28-36 (in Russian)]. doi: 10.24411/2074-1995-2019-10005
  19. Хавкин А.И., Ковтун Т.А., Макаркин Д.В., Федотова О.Б. Кисломолочные продукты и здоровье ребенка. Российский вестник перинатологии и педиатрии. 2020;65(6):155-65 [Khavkin AI, Kovtun TA, Makarkin DV, Fedotova OB. Fermented Milk Products and Child Health. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2020;65(6):155-65 (in Russian)]. doi: 10.21508/1027-4065-2020-65-6-155-165
  20. Хавкин А.И. Lactobacillus rhamnosus GG и кишечная микробиота. Вопросы детской диетологии. 2018;16(2):42-51 [Khavkin AI. Lactobacillus rhamnosus GG and intestinal microbiota. Vopr. det. dietol. (Pediatric Nutrition). 2018;16(2):42-51 (in Russian)]. doi: 10.20953/1727-5784-2018-2-42-51
  21. Комарова О.Н., Хавкин А.И. Влияние пребиотиков на пищеварительный тракт. Вопросы практической педиатрии. 2018;13(5):33-9 [Komarova ОN, Khavkin АI. Effect of prebiotics on the gastrointestinal tract. Vopr. prakt. pediatr. (Clinical Practice in Pediatrics). 2018;13(5):33-9 (in Russian)]. doi: 10.20953/1817-7646-2018-5-33-39
  22. Хавкин А.И., Блат С.Ф. Микробиоценоз кишечника и иммунитет. Российский вестник перинатологии и педиатрии. 2011;56(1):159-74 [Khavkin AI, Blat SF. Enteric microbiocenosis and immunity. Ros Vestn Perinatol Pediat. 2011;56(1):159-74 (in Russian)].
  23. Хавкин А.И., Ковтун Т.А., Макаркин Д.В., Федотова О.Б. Кисломолочные пробиотические продукты – пища или лекарство? Вопросы детской диетологии. 2021;19(3):58-68 [Khavkin AI, Kovtun TA, Makarkin DV, Fedotova OB. Probiotic fermented dairy products – food or medication? Vopr. det. dietol. (Pediatric Nutrition). 2021;19(3):58-68 (in Russian)]. doi: 10.20953/1727-5784-2021-3-58-68

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2023 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74329 от 19.11.2018 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies